Volume 19, Issue 3, May/June 2022
Cover Story
05/26/2022
Experts weigh in on 4 proposed reforms and examine each one's impact on payers, patients, providers, and the pharmaceutical industry.
Experts weigh in on 4 proposed reforms and examine each one's impact on payers, patients, providers, and the pharmaceutical industry.
Experts weigh in on 4 proposed...
05/26/2022
First Report Managed Care
Column
Viewpoint
06/06/2022
Edmund J Pezalla, MD, founder and CEO of Enlightenment Bioconsult, Hartford, CT provides insight on rare disease drug policy noting volume and indication-based contracts as potential solutions for managing costs of therapies.
Edmund J Pezalla, MD, founder and CEO of Enlightenment Bioconsult, Hartford, CT provides insight on rare disease drug policy noting volume and indication-based contracts as potential solutions for managing costs of therapies.
Edmund J Pezalla, MD, founder...
06/06/2022
First Report Managed Care
Feature
Feature
05/20/2022
Medical misinformation is a growing challenge throughout health care, exacerbated by the ubiquitous use of social media that reinforces people’s tendencies to perceive and believe in things supported by other people.
Medical misinformation is a growing challenge throughout health care, exacerbated by the ubiquitous use of social media that reinforces people’s tendencies to perceive and believe in things supported by other people.
Medical misinformation is a...
05/20/2022
First Report Managed Care
